Coulter-Parkhill A, McClean S, Gault V, Irwin N
Clin Med Insights Endocrinol Diabetes. 2021; 14:11795514211006071.
PMID: 34621137
PMC: 8491154.
DOI: 10.1177/11795514211006071.
Ampofo E, Spater T, Nalbach L, Menger M, Laschke M
Mar Drugs. 2020; 18(2).
PMID: 32074969
PMC: 7074411.
DOI: 10.3390/md18020111.
Washington A, Esponda O, Gibson A
Br J Haematol. 2019; 188(5):641-651.
PMID: 31696941
PMC: 7248351.
DOI: 10.1111/bjh.16315.
Ampofo E, Spater T, Muller I, Eichler H, Menger M, Laschke M
Mar Drugs. 2015; 13(11):6774-91.
PMID: 26569265
PMC: 4663553.
DOI: 10.3390/md13116774.
Dai A, Ye F, Taylor D, Hu G, Ginsberg M, Taylor K
J Biol Chem. 2015; 290(45):27168-27175.
PMID: 26391523
PMC: 4646401.
DOI: 10.1074/jbc.M115.682377.
Functional comparison of induced pluripotent stem cell- and blood-derived GPIIbIIIa deficient platelets.
Orban M, Goedel A, Haas J, Sandrock-Lang K, Gartner F, Jung C
PLoS One. 2015; 10(1):e0115978.
PMID: 25607928
PMC: 4301811.
DOI: 10.1371/journal.pone.0115978.
Influence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticles.
Rangger C, Helbok A, von Guggenberg E, Sosabowski J, Radolf T, Prassl R
Int J Nanomedicine. 2012; 7:5889-900.
PMID: 23226020
PMC: 3512544.
DOI: 10.2147/IJN.S36847.
Current concepts of platelet activation: possibilities for therapeutic modulation of heterotypic vs. homotypic aggregation.
Passacquale G, Ferro A
Br J Clin Pharmacol. 2011; 72(4):604-18.
PMID: 21223359
PMC: 3195737.
DOI: 10.1111/j.1365-2125.2011.03906.x.
Spatial distribution of factor Xa, thrombin, and fibrin(ogen) on thrombi at venous shear.
Berny M, Munnix I, Auger J, Schols S, Cosemans J, Panizzi P
PLoS One. 2010; 5(4):e10415.
PMID: 20454680
PMC: 2861630.
DOI: 10.1371/journal.pone.0010415.
External validation suggests Integrin beta 3 as prognostic biomarker in serous ovarian adenocarcinomas.
Partheen K, Levan K, Osterberg L, Claesson I, Sundfeldt K, Horvath G
BMC Cancer. 2009; 9:336.
PMID: 19775429
PMC: 2754489.
DOI: 10.1186/1471-2407-9-336.
The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend.
Coller B, Shattil S
Blood. 2008; 112(8):3011-25.
PMID: 18840725
PMC: 2569161.
DOI: 10.1182/blood-2008-06-077891.
Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen.
Ni H, Denis C, Subbarao S, Degen J, Sato T, Hynes R
J Clin Invest. 2000; 106(3):385-92.
PMID: 10930441
PMC: 314330.
DOI: 10.1172/JCI9896.
Thrombin-dependent calcium signalling in single human erythroleukaemia cells.
Somasundaram B, Mason M, Mahaut-Smith M
J Physiol. 1997; 501 ( Pt 3):485-95.
PMID: 9218209
PMC: 1159450.
DOI: 10.1111/j.1469-7793.1997.485bm.x.
Glanzmann thrombasthenia. Cooperation between sequence variants in cis during splice site selection.
Jin Y, Dietz H, Montgomery R, Bell W, McIntosh I, Coller B
J Clin Invest. 1996; 98(8):1745-54.
PMID: 8878424
PMC: 507612.
DOI: 10.1172/JCI118973.
Synthetic RGD peptides derived from the adhesive domains of snake-venom proteins: evaluation as inhibitors of platelet aggregation.
Lu X, Deadman J, Williams J, Kakkar V, Rahman S
Biochem J. 1993; 296 ( Pt 1):21-4.
PMID: 8250845
PMC: 1137649.
DOI: 10.1042/bj2960021.
v-jun cooperates with v-erbB to transform the thrombocytic/megakaryocytic lineage.
Garcia M, Samarut J
Proc Natl Acad Sci U S A. 1993; 90(19):8837-41.
PMID: 8105467
PMC: 47455.
DOI: 10.1073/pnas.90.19.8837.
A chromatin binding site in the tail domain of nuclear lamins that interacts with core histones.
Taniura H, Glass C, Gerace L
J Cell Biol. 1995; 131(1):33-44.
PMID: 7559784
PMC: 2120604.
DOI: 10.1083/jcb.131.1.33.
Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide....
Lu X, Williams J, Deadman J, Salmon G, Kakkar V, Wilkinson J
Biochem J. 1994; 304 ( Pt 3):929-36.
PMID: 7529494
PMC: 1137422.
DOI: 10.1042/bj3040929.
Role of thrombospondin in platelet aggregation.
Leung L
J Clin Invest. 1984; 74(5):1764-72.
PMID: 6501568
PMC: 425356.
DOI: 10.1172/JCI111595.
Characteristics of an ADP receptor mediating platelet activation.
Colman R, Figures W
Mol Cell Biochem. 1984; 59(1-2):101-11.
PMID: 6323960
DOI: 10.1007/BF00231307.